In the current study, we observed that PCAF mRNA and protein expression was significantly reduced in all stages of gastric cancer (including the earliest, or AJCC stage 1), but remained at normal levels in adjacent non-malignant or pre-malignant tissues, including in a large series of matched controls. The gene discussed is KAT2B; the disease is gastric cancer.